BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30801516)

  • 21. Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
    Hamano I; Hatakeyama S; Fujita T; Murakami R; Hamaya T; Togashi K; Suzuki Y; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Narumi S; Tomita H; Ohyama C
    Transplant Proc; 2020; 52(6):1700-1704. PubMed ID: 32448659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation.
    Cernoch M; Hruba P; Kollar M; Mrazova P; Stranavova L; Lodererova A; Honsova E; Viklicky O
    Front Immunol; 2018; 9():2310. PubMed ID: 30356754
    [No Abstract]   [Full Text] [Related]  

  • 23. Failure of neonatal B-cell tolerance induction by ABO-incompatible kidney grafts in piglets.
    Jeyakanthan M; Zhou X; Tao K; Mengel M; Rajotte RV; Larsen I; West LJ
    Transplantation; 2013 Sep; 96(6):519-28. PubMed ID: 23860083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantation.
    Del Bello A; Divard G; Belliere J; Congy-Jolivet N; Lanfranco L; Ricard R; Delas A; Colombat M; Esposito L; Hebral AL; Cointault O; Lefaucheur C; Loupy A; Kamar N
    Clin Transplant; 2019 Oct; 33(10):e13681. PubMed ID: 31369170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation.
    Toki D; Ishida H; Horita S; Yamaguchi Y; Tanabe K
    Transplantation; 2009 Nov; 88(10):1186-93. PubMed ID: 19935372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
    Masutani K; Tsuchimoto A; Kurihara K; Okabe Y; Kitada H; Okumi M; Tanabe K; Nakamura M; Kitazono T; Tsuruya K;
    Transplantation; 2017 Jun; 101(6):1416-1422. PubMed ID: 27391195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
    Kauke T; Klimaschewski S; Schoenermarck U; Fischereder M; Dick A; Guba M; Stangl M; Werner J; Meiser B; Habicht A
    PLoS One; 2016; 11(1):e0146075. PubMed ID: 26730981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M;
    Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.
    Niikura T; Yamamoto I; Nakada Y; Kamejima S; Katsumata H; Yamakawa T; Furuya M; Mafune A; Kobayashi A; Tanno Y; Miki J; Yamada H; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():75-8. PubMed ID: 26031592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings.
    Haas M; Rahman MH; Racusen LC; Kraus ES; Bagnasco SM; Segev DL; Simpkins CE; Warren DS; King KE; Zachary AA; Montgomery RA
    Am J Transplant; 2006 Aug; 6(8):1829-40. PubMed ID: 16889542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation.
    Setoguchi K; Ishida H; Shimmura H; Shimizu T; Shirakawa H; Omoto K; Toki D; Iida S; Setoguchi S; Tokumoto T; Horita S; Nakayama H; Yamaguchi Y; Tanabe K
    Am J Transplant; 2008 Jan; 8(1):86-94. PubMed ID: 18021283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of antigen-specific immunoadsorption and rebound of anti-A/B antibodies in ABO-incompatible kidney transplantation.
    Genberg H; Kumlien G; Wennberg L; Tyden G
    Nephrol Dial Transplant; 2011 Jul; 26(7):2394-400. PubMed ID: 21558429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study.
    Kwon H; Kim JY; Kim DH; Ko Y; Choi JY; Shin S; Jung JH; Kim YH; Han DJ;
    Sci Rep; 2019 Dec; 9(1):18229. PubMed ID: 31796812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mid-term efficacy evaluation of ABO incompatible living relative kidney transplantation based on protocol biopsy].
    Chen HW; He Y; Ruan HH; Wu GB; Yu SJ; Wang Y; Chen GD; Qiu J; Wang CX; Chen LZ
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(12):944-949. PubMed ID: 38514343
    [No Abstract]   [Full Text] [Related]  

  • 35. Establishment of a Hyperacute Rejection Model of ABO-Incompatible Renal Transplantation in Nonhuman Primates.
    Wang J; Feng H; Zhang C; Zhong S; Wang L; Zhu L; Chen S; Chen G
    Front Immunol; 2021; 12():807604. PubMed ID: 34970278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Microvascular Inflammation in ABO-Incompatible Kidney Transplantation.
    Ishihara H; Ishida H; Unagami K; Hirai T; Okumi M; Omoto K; Shimizu T; Tanabe K
    Transplantation; 2017 Jun; 101(6):1423-1432. PubMed ID: 27495756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired Downregulation of Donor-Specific Antibody Production After ABO-Incompatible Kidney Transplantation.
    Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Aoki T; Kamimura M; Narita I; Tomita Y; Takahashi K
    Am J Transplant; 2017 Jan; 17(1):115-128. PubMed ID: 27343838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VDJ Gene Usage of B Cell Receptors in Peripheral Blood of ABO-incompatible Kidney Transplantation Patients.
    Jeon HJ; Fang T; Lee JG; Jang JY; Kim K; Choi S; Yan JJ; Ryu JH; Koo TY; Ahn C; Yang J
    Transplant Proc; 2018 May; 50(4):1056-1062. PubMed ID: 29731065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
    Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
    Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similar Microvascular Inflammation and Tubulointerstitial Injury in ABO-Incompatible and Matched ABO-Compatible Kidney Allografts.
    Osickova K; Parikova A; Maluskova J; Fronek J; Viklicky O
    Transplant Proc; 2018 Jun; 50(5):1305-1309. PubMed ID: 29880350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.